CClinicalTrials.gg
Status unknownNCT04552639Updated Sep 2, 2021

Evaluation of Compulsive Exercise Group Therapy for Eating Disorders

An interventional study of Newbridge Eating disorders Activity Treatment group and Newbridge House treatment as usual in Eating Disorders in Adolescence, sponsored by Newbridge House. Status unknown at 1 site in United Kingdom. Open to female participants aged 11 Years to 18 Years. Per ClinicalTrials.gov, last updated 2021-09-02.

Sponsored by Newbridge House · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
11 Years to 18 Years
Sex
Female
01

Study summary

The study aims to generate hypotheses about whether a group intervention is effective in reducing motivation to compulsive exercise and/or eating disorder psychopathology when compared with a control group. This will be explored through a Randomized Control Trial.

02

Conditions studied

  • Eating Disorders in Adolescence
03

In context

Feeding and Eating Disorders

740 studies on the registry are indexed under Feeding and Eating Disorders; 159 are open to participants now.

This study's planned enrollment of 80 is close to the median of 75 across 540 interventional studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Newbridge House is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Inpatients at Newbridge House
  • Aged 11-18
  • Primary diagnosis of any form of eating disorder
  • Females

Exclusion criteria

Exclusion Criteria:

  • Previously received NEAT group at Newbridge House
  • Aged under 10 years
  • Severe learning disability
  • Inpatients without compulsive exercise behaviours
  • Day patients
  • Co-morbid psychosis
  • Males
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Treatment as usual

    Treatment as usual is offered. This includes; individual therapy, group therapy, dietetic support, occupational therapy, nursing and psychiatry, excluding the NEAT group.

    Behavioral: Newbridge House treatment as usual

  • Experimental
    Treatment as usual and NEAT group

    Treatment as usual is offered. This includes; individual therapy, group therapy, dietetic support, occupational therapy, nursing and psychiatry, alongside NEAT group.

    Behavioral: Newbridge Eating disorders Activity Treatment group

Interventions

  • BehavioralNewbridge Eating disorders Activity Treatment group

    A compulsive exercise cognitive-behavioural based group, for children and adolescents diagnosed with an eating disorder. It was devised for eating disorders including Anorexia Nervosa, Bulimia Nervosa and Other Specified Feeding or Eating Disorder. This treatment is semi-structured and problem-oriented, which focuses on tackling the factors and processes that maintain compulsive exercise behaviour.

  • BehavioralNewbridge House treatment as usual

    Multi-disciplinary eating disorder treatment (including; psychiatry, individual therapy, group therapy, dietetic support, occupation therapy and nursing excluding NEAT group).

06

What researchers measure

Primary outcomes

  1. Change in Compulsive Exercise Test

    Time frame: Week 1 and week 7

Secondary outcomes

  1. Change in Eating Disorder Examination Questionnaire

    Time frame: Week 1 and week 7

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04552639
Lead sponsor
Newbridge House
Responsible party
Gurdeep Aulakh (Assistant Psychologist, Newbridge House) — Principal investigator
First posted
Sep 17, 2020
Start date
Oct 1, 2020
Primary completion
Oct 1, 2022 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Sep 2, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion